FDA approves Roche’s MRSA test, allowing for faster screeningThe FDA has approved Roche’s MRSA test, a technology that could give healthcare providers the ability to detect Share XFDA approves Roche’s MRSA test, allowing for faster screeninghttps://pharmaphorum.com/news/fda-approves-roches-mrsa-test/
ViiV presses go on FDA filing for first-in-class HIV drug fostemsavirViiV Healthcare has fulfilled its pledge of submitting its new HIV drug fostemsavir for approval before year end, Share XViiV presses go on FDA filing for first-in-class HIV drug fostemsavirhttps://pharmaphorum.com/news/viiv-presses-go-on-fda-filing-for-first-in-class-hiv-drug-fostemsavir/
Novartis pulls rival to Roche’s risdiplam in SMA, says market limitedWhile Roche’s oral risdiplam has been tipped by some analysts to be a big contender in the market Share XNovartis pulls rival to Roche’s risdiplam in SMA, says market limitedhttps://pharmaphorum.com/news/novartis-pulls-rival-to-roches-risdiplam-in-sma-says-market-limited/
Amgen strikes outcomes-based payment plan for Enbrel with AbarcaPharmacy benefit manager Abarca has announced a US reimbursement contract with Amgen for its Enbrel (etanercept) inflammatory diseases Share XAmgen strikes outcomes-based payment plan for Enbrel with Abarcahttps://pharmaphorum.com/news/amgen-strikes-outcomes-based-payment-plan-for-enbrel-with-abarca/
Novartis says mid-stage pipeline is setting up strong growth spurtNovartis kicked off its R&D update in London this morning by pledging to bring at least 10 drugs Share XNovartis says mid-stage pipeline is setting up strong growth spurthttps://pharmaphorum.com/news/novartis-says-mid-stage-pipeline-is-setting-up-strong-growth-spurt/
US eyes faster launch for biosimilars in North American trade pact; reportsBiosimilars could be brought to market much quicker in North America if a Trump administration proposal makes it Share XUS eyes faster launch for biosimilars in North American trade pact; reportshttps://pharmaphorum.com/news/us-eyes-shorter-exclusivity-for-biologic-drugs-in-trade-pact-report/
Senate committee backs Hahn as new FDA CommissionerPresident Trump’s pick for the new FDA Commissioner – Stephen Hahn – has picked up the endorsement he Share XSenate committee backs Hahn as new FDA Commissionerhttps://pharmaphorum.com/news/senate-committee-backs-hahn-as-new-fda-commissioner/
Novartis taps Amazon know-how for ‘smart’ manufacturing, supply chainNovartis has joined forces with Amazon, drawing on the online retail giant’s technological wizardry to reduce bottlenecks and Share XNovartis taps Amazon know-how for ‘smart’ manufacturing, supply chainhttps://pharmaphorum.com/news/novartis-taps-amazons-know-how-for-smart-manufacturing-supply-chain/
Roche steps up Merck challenge with first-line NSCLC approval in USRoche has scored another FDA approval for Tecentriq alongside chemotherapy for previously-untreated, non-squamous non-small cell lung cancer (NSCLC), Share XRoche steps up Merck challenge with first-line NSCLC approval in UShttps://pharmaphorum.com/news/roche-continues-merck-challenge-with-first-line-nsclc-approval-in-us/
